The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study-Reference-Cited by-同舟云学术

The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study

Published:2022-12 Issue:12 Volume:20 Page:2921-2929
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Overvad Thure F.^ORCID,Skjøth Flemming^ORCID,Piazza Gregory^ORCID,Noble Simon^ORCID,Ording Anne G.^ORCID,Larsen Torben B.^ORCID,Nielsen Peter B.^ORCID

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15883

Reference51 articles.

1. Increasing incidence and declining mortality after cancer‐associated venous thromboembolism: a nationwide cohort study;Ording;Am J Med,2021

2. Venous thromboembolism in cancer patients: a population‐based cohort study;Mulder;Blood,2021

3. Venous thromboembolism: the patient perspective;Kevane;Thromb Update,2021

4. Risk of recurrent venous thromboembolism: a Danish nationwide cohort study;Albertsen;Am J Med,2018

5. Development and validation of a predictive model for chemotherapy‐associated thrombosis;Khorana;Blood,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between pembrolizumab and risk of venous thromboembolism in patients with breast cancer;Thrombosis Research;2024-10

2. Thrombotic events associated with immune checkpoint inhibitors and novel antithrombotic strategies to mitigate bleeding risk;Blood Reviews;2024-09

3. Positive predictive value and sensitivity of cancer-associated venous thromboembolism diagnoses in the Danish National Patient Register;Thrombosis Research;2024-09

4. New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis;Bleeding, Thrombosis and Vascular Biology;2024-05-16

5. Immune checkpoint inhibitor-associated cardiovascular toxicities: A review;Heliyon;2024-03